A closer look at “STAT+: A new trick for old science, and biotech VCs’ scrambled playbook”, exactly as the source publishes it. CAR-T promise in autoimmunity, GSK's goodbye to leucovorin, and more biotech news Nova Global News curates publicly available headlines and summaries with source attribution. Third-party article rights, trademarks, images, and publisher names belong to their respective owners;
read the original article at the source for full context. Part of the Nova Ecosystem — the platform where AI apps, news, and tools are built and deployed. The full version stays on the original page, which this listing opens directly.